Shenzhen New Industries Biomedical Engineering Co., Ltd. Stock

Equities

300832

CNE100003T39

Medical Equipment, Supplies & Distribution

End-of-day quote Shenzhen S.E. 06:00:00 2024-04-22 pm EDT 5-day change 1st Jan Change
68.23 CNY +5.16% Intraday chart for Shenzhen New Industries Biomedical Engineering Co., Ltd. +7.55% -12.75%
Sales 2024 * 4.92B 679M Sales 2025 * 6.24B 861M Capitalization 53.61B 7.4B
Net income 2024 * 2.06B 284M Net income 2025 * 2.63B 363M EV / Sales 2024 * 10.6 x
Net cash position 2024 * 1.59B 219M Net cash position 2025 * 1.86B 257M EV / Sales 2025 * 8.3 x
P/E ratio 2024 *
26 x
P/E ratio 2025 *
20.4 x
Employees 2,627
Yield 2024 *
1.83%
Yield 2025 *
2.29%
Free-Float 39.42%
More Fundamentals * Assessed data
Dynamic Chart
Shenzhen New Industries Biomedical Engineering Gets Nod to Register Five Devices MT
Shenzhen New Industries Biomedical Engineering's 2023 Profit Jumps 25% MT
Shenzhen New Industries Biomedical Engineering Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Nomura Adjusts New Industries Biomedical Engineering’s Price Target to 98.15 Yuan From 86.13 Yuan, Keeps at Buy MT
Nomura Adjusts Shenzhen New Industries Biomedical Engineering's Price Target to 86.13 Yuan From 75.19 Yuan, Keeps at Buy MT
Shenzhen New Industries Biomedical Engineering Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023 CI
Nomura Adjusts Shenzhen New Industries Biomedical Engineering's Price Target to 75.19 Yuan From 71.58 Yuan, Keeps at Buy MT
Shenzhen New Industries' Profit Jumps 32% in H1 MT
Shenzhen New Industries Biomedical Engineering Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023 CI
Nomura Adjusts Shenzhen New Industries Biomedical Engineering’s Price Target to 71.58 Yuan From 69.88 Yuan, Keeps at Buy MT
Shenzhen New Industries Biomedical Engineering Co., Ltd. Announces Final Profit Distribution Plan to Be Implemented on A Shares for the Year 2022, Payable on 08 June 2023 CI
Shenzhen New Industries Biomedical Engineering's Shareholders Plan To Unload Company Stakes CI
Certain A Shares of Shenzhen New Industries Biomedical Engineering Co., Ltd. are subject to a Lock-Up Agreement Ending on 12-MAY-2023. CI
Nomura Adjusts New Industries Biomedical's Price Target to 69.88 Yuan From 71.05 Yuan, Keeps at Buy MT
Shenzhen New Industries Biomedical Engineering Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
More news
1 day+5.16%
1 week+7.55%
Current month+3.16%
1 month-12.15%
3 months-6.46%
6 months+12.68%
Current year-12.75%
More quotes
1 week
60.81
Extreme 60.81
68.56
1 month
60.81
Extreme 60.81
79.50
Current year
60.81
Extreme 60.81
83.50
1 year
49.86
Extreme 49.86
83.50
3 years
31.76
Extreme 31.76
83.50
5 years
19.83
Extreme 19.8263
107.41
10 years
19.83
Extreme 19.8263
107.41
More quotes
Managers TitleAgeSince
Chief Executive Officer 60 12-08-16
Director of Finance/CFO 49 04-09-30
Director/Board Member 31 16-05-31
Members of the board TitleAgeSince
Director/Board Member 49 12-07-31
Chief Executive Officer 60 12-08-16
Director/Board Member 61 18-09-09
More insiders
Date Price Change Volume
24-04-24 69.15 +1.35% 3,233,593
24-04-23 68.23 +5.16% 5,461,850
24-04-22 64.88 +0.31% 3,111,965
24-04-19 64.68 +0.40% 3,212,968
24-04-18 64.42 +2.53% 6,565,481

End-of-day quote Shenzhen S.E., April 22, 2024

More quotes
Shenzhen New Industries Biomedical Engineering Co Ltd is a company engaged in research and development, production and sales of in-vitro diagnostics instruments and supporting reagents. The Company operates three segments, including Instruments and Supporting Software, Reagents, Accessories and Others. Instruments and Supporting Software segment is involved in the production and sales of MAGLUMI automatic chemiluminescence immunoassay analyzer series products and Biossays automatic biochemical analyzer series products. Reagents segment operates the sales of supporting reagents for the analyzers. The products are applied in the examination of Gonads, thyroid gland, glucose metabolism, kidney function and so on. Accessories and Others segment is responsible for the manufacturing and sales of accessories related to in-vitro diagnostics equipment. The Company sells its products both in domestic and international markets, including Asia, Europe, America and Africa.
Calendar
More about the company
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
13
Last Close Price
68.23 CNY
Average target price
83.35 CNY
Spread / Average Target
+22.17%
Consensus
  1. Stock Market
  2. Equities
  3. 300832 Stock